Pharmacodynamic Biomarkers to Support Biosimilar Development: Interferon Beta-1A Products
Clinical trial NCT04183491 · COMPLETED
Trial details
- NCT number
- NCT04183491
- Sponsor
- Food and Drug Administration (FDA)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-28
- Primary completion
- 2021-01-26
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.